Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Eitemau Tebyg

• Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy
  gan: Silk, J, et al.
  Cyhoeddwyd: (2004)
• NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
  gan: Hermans, I, et al.
  Cyhoeddwyd: (2003)
• Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
  gan: Hermans, I, et al.
  Cyhoeddwyd: (2007)
• Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.
  gan: Reddy, BG, et al.
  Cyhoeddwyd: (2009)
• Biology of CD1- and MR1-restricted T cells.
  gan: Salio, M, et al.
  Cyhoeddwyd: (2014)